Similar articles

• Treatment of parkinsonism.

  Calne DB, Teychenne PF, Pfeiffer RF. Calne DB, et al. Adv Exp Med Biol. 1977;90:49-61. doi: 10.1007/978-1-4684-2511-6_3. Adv Exp Med Biol. 1977. PMID: 930750 No abstract available.
• Therapeutic approaches in Parkinson's disease: possible roles of growth hormone and somatostatin.

  Cotzias GC, Papavasiliou PS, Ginos JZ. Cotzias GC, et al. Res Publ Assoc Res Nerv Ment Dis. 1976;55:305-15. Res Publ Assoc Res Nerv Ment Dis. 1976. PMID: 1005904 No abstract available.
• Editorial: Dopa decarboxylase inhibitors.

  [No authors listed] [No authors listed] Br Med J. 1974 Nov 2;4(5939):250-1. doi: 10.1136/bmj.4.5939.250. Br Med J. 1974. PMID: 4425849 Free PMC article. No abstract available.
• Sinemet and the treatment of Parkinsonism.

  Boshes B. Boshes B. Ann Intern Med. 1981 Mar;94(3):364-70. doi: 10.7326/0003-4819-94-3-364. Ann Intern Med. 1981. PMID: 7013595 Review.
• Treatment of parkinsonism.

  Selby G. Selby G. Drugs. 1976;11(1):61-70. doi: 10.2165/00003495-197611010-00006. Drugs. 1976. PMID: 770132 Review.